United Imaging[email protected]Top StoriesMRIPI-RADS v2.1 is 'highly sensitive' for prostate cancer detection on MRIPI-RADS v2.1 was developed by the ACR and the European Society of Urogenital Radiology (ESUR) and released in 2019.UltrasoundqHDMI differentiates radial scars from invasive breast cancerInterventionalLung biopsy before surgery linked to cancer recurrenceCTAbnormal CT-FFR results translate to up to 7 years of cardiovascular riskSponsor ContentRegister Now: Breaking Barriers in Breast Imaging Webinar